ExoticRx · exoticrx.com/drugs/cilostazol
US brand names:Pletal
Cilostazol is dosed at 2–5 mg/kg PO q12h in dogs, per Corroborated 2026-07-31: Ohmori T, Matsumura Y, Yoshimura A, et al. Front Vet Sci 2022;9:954295. doi:10.3389/fvets.2022.954295 PMID:36061105 - dog, cilostazol 5-10 mg/kg PO q12h (59-dog retrospective series; range 3.5-37.5 mg/kg/day). Studied for BRADYARRHYTHMIA only; thrombosis indication is extrapolated.. Verify against current literature before clinical use.
Selective phosphodiesterase-3 inhibitor that increases cAMP in platelets and vascular smooth muscle, inhibiting platelet aggregation and causing vasodilation.
Contraindicated in heart failure. Headache, diarrhea. Avoid with CYP3A4 and CYP2C19 inhibitors. Limited veterinary use for peripheral vascular disease.
Species references:All Cat (Domestic) drugsAll Dog (Domestic) drugs
Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.
A dog/cat sample is shown here. Cited dosing for all 2 species — reptiles, birds, pocket pets, livestock, and equine — is free on the per-species pages above. Pro adds the weight-based calculator for every species.
| Species | Route | Dose | Frequency | Evidence | Source |
|---|---|---|---|---|---|
| Dog (Domestic) | PO | 2–5 mg/kg | q12h | Weak | Corroborated 2026-07-31: Ohmori T, Matsumura Y, Yoshimura A, et al. Front Vet Sci 2022;9:954295. doi:10.3389/fvets.2022.954295 PMID:36061105 - dog, cilostazol 5-10 mg/kg PO q12h (59-dog retrospective series; range 3.5-37.5 mg/kg/day). Studied for BRADYARRHYTHMIA only; thrombosis indication is extrapolated. |
| Cat (Domestic) | PO | 2–5 mg/kg | q12h | Extrapolated | Source not established. The citation previously shown here named no retrievable document; a literature search on 2026-07-31 found no source that states this dose for this species and route. Treat as unverified and confirm against a primary reference before clinical use. |
Upgrade to Pro or Student to unlock the full dose ranges and frequency for every species. The drug's mechanism, warnings, indications, and cited sources are free to read.
View PlansSource citations and evidence levels available on the live page. Reference only — verify against current literature before clinical use.